Filing Details

Accession Number:
0001179110-14-003416
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-24 14:20:15
Reporting Period:
2014-02-20
Filing Date:
2014-02-24
Accepted Time:
2014-02-24 14:20:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489966 Q Charles Morris C/O Immunogen, Inc.
830 Winter Street
Waltham MA 02451
Executive Vp & Cdo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-20 13,672 $11.93 51,172 No 4 M Direct
Common Stock Disposition 2014-02-20 13,672 $17.10 37,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-02-20 13,672 $11.93 13,672 $11.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
179,190 2013-11-26 2022-11-26 No 4 M Direct
Footnotes
  1. Weighted average price of shares sold.
  2. The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on August 29, 2013.
  3. Exercisable as to 50,000 shares commencing on November 26, 2013, 50,000 shares commencing on November 26, 2014, 50,000 shares commencing on November 26, 2015, and 50,000 shares commencing on November 26, 2016.